LANOXIN
NDC 59212-240, digoxin, tablet, from Advanz Pharma (US) Corp..
- Product NDC
- 59212-240
- Status
- Listed
- Labeler
- Advanz Pharma (US) Corp.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020405
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59212-240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIGOXIN.0625 mg/1
Pharmacologic classes
Cardiac Glycoside [EPC]; Cardiac Glycosides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59212-240-55 | 59212024055 | 100 TABLET in 1 BOTTLE (59212-240-55) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/d91e3646-4c63-4512-ab22-db39c085c4dc
Use it
Look up 59212-240 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59212-240 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59212-240. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.